Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2022-01-28 | 2022-02-08 | 153780 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2022-02-04 | 2022-04-01 | 154168 |
APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154175 |
APO-LISINOPRIL | 10MG | TABLET | Resolved | 2022-02-04 | 2022-03-24 | 154178 |
APO-MODAFINIL | 100MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154181 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2022-02-04 | 2022-02-28 | 154184 |
APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2022-02-04 | 2022-04-15 | 154187 |
APO-RISEDRONATE | 150MG | TABLET | Resolved | 2022-02-04 | 2022-03-07 | 154197 |
APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2022-02-04 | 2022-05-06 | 154205 |
APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2022-02-04 | 2022-07-11 | 154208 |
APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2022-02-11 | 2022-02-18 | 154749 |
APO-CEPHALEX | 500MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154753 |
APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154756 |
APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154759 |
APO-IBUPROFEN | 200MG | TABLET | Resolved | 2022-02-11 | 2022-05-14 | 154762 |
APO-PROPAFENONE | 150MG | TABLET | Resolved | 2022-02-11 | 2022-03-25 | 154765 |
APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2022-02-11 | 2022-03-25 | 154770 |
APO-AMLODIPINE-ATORVASTATIN | 20MG 10MG | TABLET | Resolved | 2022-02-18 | 2022-04-01 | 155308 |
APO-CETIRIZINE | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-01 | 155311 |
APO-IMATINIB | 400MG | TABLET | Resolved | 2022-02-18 | 2022-03-21 | 155314 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2019-08-08 | 60420 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2018-09-15 | 60438 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-08-07 | 2019-08-07 | 91117 |
APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4909 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO-ZOLMITRIPTAN RAPID | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-09-08 | 2018-09-15 | 60867 |